AKT1 and breast cancer: The results of our study reflect the high potential of CDDP conjugated with SWCNT-COOH in promoting cell death, downregulation of PI3K/Akt signaling, and inhibition of breast cancer cell migration, and could contribute to the development of new strategies for targeted treatment against highly proliferative and metastatic breast cancer.